Skip to main content
TipRanks
Go Ultimate75% OFF

MICHAEL P. COOKE Insider Profile

4 Followers

MICHAEL P. COOKE, CSO at Dianthus Therapeutics, holds 240.52K shares in Dianthus Therapeutics (Ticker: DNTH). Most recently, MICHAEL P. COOKE Sold 7,500 shares of Dianthus Therapeutics on Dec 02, 2019 for an estimated value of $97.47K.

MICHAEL P. COOKE's Trading History

DNTH
Dianthus Therapeutics
Dec 02, 2019CSOInformative Sell97.47K$22.08M
DNTH
Insider Shares: 240.52K (0.62%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 02, 2019Informative Sell$97.47K7,500$12.99+42.30%
Nov 25, 2019Informative Sell$60.00K5,000$12.00+47.80%
Nov 01, 2019Informative Sell$53.30K5,000$10.66+44.50%
Oct 03, 2019Informative Sell$50.05K5,000$10.01+34.50%
Sep 19, 2019Uninformative Sell$19.87K1,656$12.00―

You May Also Like

MICHAEL P. COOKE insider profile FAQ

What is the percentage of profitable transactions made by MICHAEL P. COOKE?
The percentage of profitable transactions made by MICHAEL P. COOKE is 100%.
What is the average return per transaction made by MICHAEL P. COOKE?
The average return per transaction made by MICHAEL P. COOKE is 42.20%.
What stocks does MICHAEL P. COOKE hold?
MICHAEL P. COOKE holds: DNTH stocks.
What was MICHAEL P. COOKE’s latest transaction?
MICHAEL P. COOKE’s latest transaction was an Informative Sell of $97.47K.
What was MICHAEL P. COOKE's most profitable transaction?
MICHAEL P. COOKE’s most profitable transaction was an Informative Sell of DNTH stock on November 25, 2019. The return on the trade was 47.80%.
What is MICHAEL P. COOKE's role in Dianthus Therapeutics?
MICHAEL P. COOKE's role in Dianthus Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.